(Q35784044)

10 August 2017

1 reference

title

Pharmacological strategies in relieving neuropathic pain (English)

1 reference

10 August 2017

0 references

Gary McCleane

1

1 reference

PubMed ID

15163275

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Pharmacotherapy

10 August 2017

1 reference

10 August 2017

5

1 reference

10 August 2017

6

1 reference

10 August 2017

1299-1312

1 reference

Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine

10 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Oral opioid therapy for chronic peripheral and central neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Clinical pharmacology of opioids for pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Direct inhibition of the N-methyl-D-aspartate receptor channel by high concentrations of opioids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Fentanyl decreases Ca2+ currents in a population of capsaicin-responsive sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Affinities of dihydrocodeine and its metabolites to opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Cholecystokinin/opioid interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Opioid receptors on peripheral sensory axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Amitriptyline versus placebo in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Central post-stroke pain--a controlled trial of amitriptyline and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Desipramine relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neurological cultures from rat cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Lamotrigine in the management of neuropathic pain: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Lamotrigine in the treatment of chronic refractory neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Lamotrigine in spinal cord injury pain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Lamotrigine for central poststroke pain: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Reflex sympathetic dystrophy treated with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

21 January 2018

Sodium channels and pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Capsaicin and sensory neurones — a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Post-herpetic neuralgia and topical capsaicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Capsaicin for the treatment of pain in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Ketamine in chronic pain management: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Early history of IBRO: the birth of organized neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Pain pathways and parabrachial circuits in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Does a Single Intravenous Injection of the 5HT3 Receptor Antagonist Ondansetron Have an Analgesic Effect in Neuropathic Pain? A Double-Blinded, Placebo-Controlled Cross-Over Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Distinct cholecystokinin receptors in brain and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Increased level of cholecystokinin in cerebrospinal fluid is associated with chronic pain-like behavior in spinally injured rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Effects of peripheral axotomy on cholecystokinin neurotransmission in the rat spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

The cholecystokinin antagonist proglumide enhances the analgesic effect of dihydrocodeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Topical application of doxepin hydrochloride can reduce the symptoms of complex regional pain syndrome: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Pregabalin in patients with postoperative dental pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Low dose of tetrodotoxin reduces neuropathic pain behaviors in an animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1299

10.1517/14656566.5.6.1299

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15163275